Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients

Overview of attention for article published in Trials, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 25,314 followers.

RT @UCLANeurology: Platform trials are well-known for their ability to investigate multiple patient populations and their flexibility to ad…

16 Sep 2022

Reply Repost Favourite

RT @UCLANeurology: Platform trials are well-known for their ability to investigate multiple patient populations and their flexibility to ad…

16 Sep 2022

Reply Repost Favourite

Platform trials are well-known for their ability to investigate multiple patient populations and their flexibility to add/drop treatment arms. This study with Dr. Jeffrey Saver optimizes a platform trial design for #stroke patients. #neurotwitter https

16 Sep 2022

Reply Repost Favourite

Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients https://t.co/xV9R38HmkB

07 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.